Xetra
19.03.26 | 17:35
31,770 Euro
-1,63 % -0,525
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 32,035 | 32,250 | 19.03. | |
| 32,060 | 32,115 | 19.03. |
► 19.03.: | | | | | | |
| |
► 18.03.: | | | | | | | | | 17:30
► Aktueller NOVO NORDISK Börsenkurs + Xetra-Orderbuch
► 18.03.: | | | | | | | | | 17:30
► Aktueller NOVO NORDISK Börsenkurs + Xetra-Orderbuch
| Stück | Geld | Kurs | Brief | Stück |
|---|---|---|---|---|
| 34,150 | 100 | |||
| 33,000 | 170 | |||
| 32,850 | 2.150 | |||
| 32,500 | 33 | |||
| 32,200 | 1.000 | |||
| 31,975 | 498 | |||
| 31,845 | 350 | |||
| 31,835 | 350 | |||
| 31,825 | 686 | |||
| 31,805 | 243 | |||
Quelle: [URL] https://aktienkurs-orderbuch.finanznachrichten.de/nov.htm [/URL] | ||||
| 243 | 31,745 | |||
| 686 | 31,720 | |||
| 350 | 31,710 | |||
| 350 | 31,700 | |||
| 498 | 31,685 | |||
| 80 | 31,320 | |||
| 700 | 31,250 | |||
| 300 | 31,220 | |||
| 100 | 31,120 | |||
| 40 | 31,100 | |||
| Summe Aktien im Kauf | Verhältnis | Summe Aktien im Verkauf | ||
| 3.347 | 1,667 | 5.580 | ||
| Uhrzeit | Aktienkurs | Stück |
|---|---|---|
| 17:35:36 | 31,770 | 6.404 |
| 17:29:47 | 31,750 | 9 |
| 17:29:47 | 31,750 | 16 |
| 17:29:47 | 31,765 | 32 |
| 17:27:30 | 31,815 | 9.930 |
| 17:27:30 | 31,815 | 70 |
| 17:26:42 | 31,825 | 8.271 |
| 17:26:38 | 31,825 | 1.700 |
| 17:26:32 | 31,825 | 29 |
| 17:26:22 | 31,830 | 150 |
| 17:26:20 | 31,825 | 22 |
| 17:26:20 | 31,825 | 1 |
| 17:26:20 | 31,825 | 3 |
| 17:26:14 | 31,825 | 436 |
| 17:25:00 | 31,820 | 1 |
| 17:24:46 | 31,830 | 30 |
| 17:24:08 | 31,840 | 825 |
| 17:24:08 | 31,840 | 30 |
| 17:23:07 | 31,810 | 56 |
| 17:23:07 | 31,810 | 9 |
| Tagesumsatz Xetra | -0,525 -1,63 % | 376.232 |
Angaben in grüner Schrift zeigen, dass der Aktienkurs im Vergleich zum vorherigen Kurs gestiegen ist. Angaben in roter Schrift zeigen gefallene Börsenkurse.
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | FDA approves higher Wegovy dose via 4th priority voucher | 14 | pharmaphorum | ||
| Do | Novo uses FDA voucher to win speedy approval of higher-dose Wegovy | 7 | BioPharma Dive | ||
| Do | Novo's Wegovy HD passes muster under FDA national priority voucher program | 21 | FiercePharma | ||
| Do | FDA approves new higher-dose version of Wegovy shots | 14 | BNN Bloomberg | ||
| NOVO NORDISK Aktie jetzt für 0€ handeln | |||||
| Do | Novo Nordisk Secures FDA Approval For Higher-Dose Wegovy | 21 | Benzinga.com |
1 2 3 4 5 Weiter >>
2.704 Nachrichten in den letzten 12 Monaten
| Zeit | Aktuelle Nachrichten | Medien | ||
|---|---|---|---|---|
| Do | Cosmos Health Inc.: Cosmos Health Provides Update; Evaluates Options to Address Valuation Disconnect; Will Issue Updated Guidance Following FY 2025 Results; Record Growth Continues as Significant U.S. Expansion Underway, with Additional $12M+ in High-Marg | GlobeNewswire (Europe) | Continues to deliver record revenue and improving operating metricsSignificant expansion in the United States underway, with NOOR and other Sky Premium Life products expected to drive strong profitability
supported... ► Artikel lesen | |
| Do | OXURION: Oxurion signs a letter of intent for the acquisition of an international CRO | Actusnews Wire | Leuven, BELGIUM - March 19, 2026 - 18:30 PM CET - Oxurion NV (Euronext Brussels: OXUR), a pharmaceutical outsourcing company based in Leuven, announces the signing of a letter of intent (LOI) for... ► Artikel lesen | |
| Do | Teva Pharmaceutical Industries Ltd: Teva to Host Conference Call to Discuss First Quarter 2026 Financial Results at 8 a.m. ET on April 29, 2026 | GlobeNewswire (Europe) | TEL AVIV, Israel and PARSIPPANY, N.J., March 19, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its first quarter... ► Artikel lesen | |
| Do | Defensive Biotech-Wetten? Warum Amgen und AbbVie strukturell wachsen - kleiner Player Mesoblast im Fokus | Small- & Micro Cap Investment | ||
| Do | XFRA 0NF1: AUSSETZUNG/SUSPENSION | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILNOVERIS HEALTH SCI.... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NOVO NORDISK A/S finden Sie auf Wallstreet Online.